• Latest Posts
Sponsored by 10 Mar 2023

Meet some of the biotechs attending Bio-Europe Spring 2023

Newron reports ‘striking’ schizophrenia study results 

Beyond Biotech podcast 28: Mainz Biomed, Newron Pharmaceuticals

Newron announces interim results from treatment-resistant schizophrenia trial

Phase III Failure Sinks Drug for Rare Neurological Disorder

British Researchers Find Thought Police to Treat Neurological Disorders


UPDATE: Italian Pharma receives €11M for Parkinson’s Drug Approval

Interview 20 Apr 2017

Newron’s Journey to Launch the First Parkinson’s Drug in 11 Years

Infographics 21 Feb 2017

Infographic: The Biggest Biotech Company in Each European Country

World Mental Health Day: How is Biotech Helping the Cause?

New Italian Drug is FDA approved for trials in Rare Neurological Disease